BELLUS Financial Statements From 2010 to 2024
| BLUDelisted Stock | USD 14.74 0.00 0.00% |
Check BELLUS Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BELLUS main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . BELLUS financial statements analysis is a perfect complement when working with BELLUS Health Valuation or Volatility modules.
BELLUS |
BELLUS Health Company Shares Outstanding Analysis
BELLUS Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BELLUS Health Shares Outstanding | 126.81 M |
Most of BELLUS Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BELLUS Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, BELLUS Health has 126.81 M of shares currently outstending. This is 29.76% lower than that of the Biotechnology sector and 18.68% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 77.82% higher than that of the company.
BELLUS Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BELLUS Health's current stock value. Our valuation model uses many indicators to compare BELLUS Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BELLUS Health competition to find correlations between indicators driving BELLUS Health's intrinsic value. More Info.BELLUS Health is rated fifth in return on equity category among related companies. It is rated fourth in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value BELLUS Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BELLUS Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BELLUS Health's earnings, one of the primary drivers of an investment's value.About BELLUS Health Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include BELLUS Health income statement, its balance sheet, and the statement of cash flows. BELLUS Health investors use historical funamental indicators, such as BELLUS Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although BELLUS Health investors may use each financial statement separately, they are all related. The changes in BELLUS Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BELLUS Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BELLUS Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BELLUS Health. Please read more on our technical analysis and fundamental analysis pages.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BELLUS Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BELLUS Health's short interest history, or implied volatility extrapolated from BELLUS Health options trading.
Pair Trading with BELLUS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BELLUS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BELLUS Health will appreciate offsetting losses from the drop in the long position's value.Moving together with BELLUS Stock
| 0.64 | CVI | CVR Energy Financial Report 6th of May 2024 | PairCorr |
Moving against BELLUS Stock
| 0.74 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.53 | BA | Boeing Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to BELLUS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BELLUS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BELLUS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BELLUS Health to buy it.
The correlation of BELLUS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BELLUS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BELLUS Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BELLUS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in BELLUS Stock
If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |